Pharmaceutical companies have long provided physicians with complimentary meals, drug samples, gifts, and speaking fees, raising concerns that such generosity may unduly shape prescribing behavior.
However, the extent to which these interactions have altered physicians’ behavior over time remains a key question.
A recent study seeks to address this issue. Researchers surveyed 283 physicians, part of a larger cohort of over 1,300 medical students and residents originally assessed in 2011, and revisited the data two years later. Their findings indicate that the debate surrounding physician‑industry interactions is expected to stay contentious.
